2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 52.155 | 49.512 | 56.103 | 89.331 | 81.976 | 83.669 | 73.183 | 110.898 | 157.184 | 294.981 |
Total Income - EUR | 52.157 | 52.821 | 56.103 | 89.742 | 82.193 | 84.716 | 73.210 | 110.913 | 157.969 | 298.942 |
Total Expenses - EUR | 34.148 | 37.205 | 38.426 | 57.049 | 59.003 | 57.214 | 56.683 | 66.433 | 78.587 | 96.346 |
Gross Profit/Loss - EUR | 18.009 | 15.616 | 17.677 | 32.693 | 23.190 | 27.502 | 16.527 | 44.480 | 79.382 | 202.596 |
Net Profit/Loss - EUR | 16.444 | 14.031 | 17.116 | 29.557 | 22.368 | 26.655 | 16.127 | 43.606 | 78.007 | 200.058 |
Employees | 2 | 4 | 5 | 8 | 6 | 4 | 4 | 4 | 3 | 4 |
Check the financial reports for the company - Medicart Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 10.990 | 5.243 | 2.921 | 967 | 23.751 | 16.906 | 162.346 | 149.989 | 144.344 | 144.898 |
Current Assets | 62.398 | 48.674 | 66.834 | 59.904 | 42.612 | 40.870 | 46.174 | 25.204 | 72.620 | 62.758 |
Inventories | 45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 803 | 0 | 4.333 | 5.885 | 2.087 | 20.013 | 40.946 | 260 | 42.999 | 35.906 |
Cash | 61.550 | 48.674 | 62.501 | 54.019 | 40.525 | 20.856 | 5.228 | 24.944 | 29.621 | 26.853 |
Shareholders Funds | 16.497 | 14.085 | 17.169 | 29.610 | 22.420 | 26.706 | 42.326 | 49.075 | 78.055 | 200.106 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 61.508 | 41.788 | 52.586 | 31.261 | 43.944 | 31.070 | 166.194 | 126.118 | 138.909 | 7.550 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Medicart Srl